Active Ingredients: Ciprofloxacin
You acknowledge that the recommendations and information in the Materials do not indicate an exclusive course of treatment or serve as a standard of medical care.
Limitation of Liability and Damages. You agree that Lexi-Comp, Inc. The Lexi-Comp Content is intended to serve the user as a rapidly accessible, concise initial reference resource and not as a complete reference resource.
It does not include information concerning every therapeutic agent, laboratory or diagnostic test or procedure available. The Lexi-Comp Content is clinically oriented and is intended to be used only by Users who are: 1 researchers who will not use the information for medical diagnosis or treatment, and 2 physicians and other competent healthcare professionals who will rely on their own discretion and judgment in medical diagnosis and treatment.
Neither the AAP nor its Providers directly or indirectly practice medicine or dispense medical services and, as such, assume no liability for data contained in the Lexi-Comp Content.
Except for your obligations hereunder to pay the AAP, neither party shall be responsible for delays or failures in performance resulting from acts or circumstances beyond the control of such party, including, without limitation, acts of God, strikes or other labor disputes, riots, acts of war, malfunction of portions of the Internet or another third party network, governmental regulations promulgated after the effective date of this Agreement, communication line failures, power failures, equipment failures, fires or other disasters, and acts of third parties including hackers and crackers.
The AAP reserves the right to change or modify this Agreement at any time by presenting you with a new set of terms before you access the Materials.
No outcomes in this study. Isolation of Haemophilus influenzae and Haemophilus parainfluenzae in urethral exudates from men with acute urethritis: a descriptive study of 52 cases.
Sex Transm Infect. J Acquir Immune Defic Syndr. Haemophilus influenzae serotype a as a cause of serious invasive infections.
Lancet Infect Dis. Laboratory surveillance has primarily identified the US and Canada as where most clinical infections have been described.
For reasons that are unclear, the incidence of invasive Hia infection is lower in Europe. Much as had been the case for Hib, invasive Hia strikes children mostly ages 6 months to 2 years.
The majority of the remaining culture results were negative.